{"DataElement":{"publicId":"2787667","version":"1","preferredName":"in vivo Immunotoxin Administered Specify Text","preferredDefinition":"The free-text field to describe the in vivo immunotoxin that was administered.","longName":"INV_IMTX_ADMIN_SPC","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2787608","version":"1","preferredName":"in vivo Immunotoxin Administered","preferredDefinition":"Located or occurring in the body._Agents comprised of various toxic molecules (Radioactive Isotopes and Bacterial or Plant Toxins) conjugated with specific immune substances (Immunoglobulins, Monoclonal Antibodies, and Antigens) that targets affected cells allowing incorporation of the toxin into the cells._The act of having given something (e.g., a medication or test).","longName":"INV_IMTX_ADMIN","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2862142","version":"1","preferredName":"in vivo Immunotoxin","preferredDefinition":"Located or occurring in the body; the opposite of in vitro (located or occurring outside the body).:Agents comprised of various toxic molecules (Radioactive Isotopes and Bacterial or Plant Toxins) conjugated with specific immune substances (Immunoglobulins, Monoclonal Antibodies, and Antigens)that targets affected cells allowing incorporation of the toxin into the cells.(NCI)","longName":"C15744:C575","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"In Vivo","conceptCode":"C15744","definition":"Located or occurring in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunotoxin","conceptCode":"C575","definition":"Agents comprised of various toxic molecules (Radioactive Isotopes and Bacterial or Plant Toxins) conjugated with specific immune substances (Immunoglobulins, Monoclonal Antibodies, and Antigens) that targets affected cells allowing incorporation of the toxin into the cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6817944D-C083-67BC-E040-BB89AD433956","latestVersionIndicator":"Yes","beginDate":"2009-04-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-04-21","modifiedBy":"ONEDATA","dateModified":"2009-04-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57BB3DD9-53B6-3B25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-25","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-09-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2799057","version":"1","preferredName":"Specify Text","preferredDefinition":"Be specific about something; define clearly._Text; the words of something written.","longName":"SPC_TXT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2799056","version":"1","preferredName":"Specify Text","preferredDefinition":"Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D89B-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"ONEDATA","dateModified":"2008-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D8AC-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"MALUMK","dateModified":"2021-01-19","changeDescription":"03/17/10-Added CSI for F2000-CJL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"}]},{"publicId":"2842912","version":"1","longName":"Therapy","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2842918","version":"1","longName":"Administration","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"agvhd_prevent_immtx_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"agvhd_trt_immunotx_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"MaterialName:name","type":"HCT_BRIDG","context":"NHLBI"},{"name":"HPST_AGHD_in_vivo_immunotox_sp","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_p_in_vivo_immntox_sp","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the in vivo immunotox","type":"Preferred Question Text","description":"Specify the in vivo immunotoxin administered:","url":null,"context":"NHLBI"},{"name":"Specify:","type":"Alternate Question Text","description":"Specify:","url":null,"context":"NHLBI"},{"name":"Specify the in vivo immunotoxin used after the start of the preparative regimen to prevent acute GVHD or graft rejection?","type":"Alternate Question Text","description":"Specify the in vivo immunotoxin used after the start of the preparative regimen to prevent acute GVHD or graft rejection?","url":null,"context":"NHLBI"},{"name":"Specify immunotoxin","type":"Alternate Question Text","description":"Specify immunotoxin","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2787667","type":"BRIDG Mapping Path","description":"PerformedProcedure > DefinedActivity > Product > MaterialName.name WHERE Product.typeCode = \"In Vivo Immunotoxin\"","url":null,"context":"NHLBI"},{"name":"Specify immunotoxin:","type":"Application Standard Question Text","description":"Specify immunotoxin:","url":null,"context":"NHLBI"},{"name":"Specify immunotoxin:","type":"Alternate Question Text","description":"Specify immunotoxin:","url":null,"context":"NHLBI"},{"name":"Specify in vivo immunotoxin:","type":"Alternate Question Text","description":"Specify in vivo immunotoxin:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57BD161D-08D6-1D29-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-25","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-09-25","modifiedBy":"MALUMK","dateModified":"2021-10-04","changeDescription":". Added alt name/ASQT for 2400. AK 10/9/13 Added human readable def. System generated def displayed as alt def. No version needed. AK 10/7/14 Alt name. \"PreTed_gvhd_prophy_in_vivo_immunotox_spec\" removed due to being used on CDE 3837871. AK 8/24/16. AQT added for 2100r7. 03/24/2021 KMM. ALT name added for 2100r7. 10/04/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}